Leonard Schaeffer joins scPharmaceuticals Board of Directors

FOR IMMEDIATE RELEASE: LEXINGTON, Mass. /PRNewswire/ — scPharmaceuticals, Inc., a privately held pharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that Leonard D. Schaeffer has been appointed to scPharmaceutical’s board of directors. Mr. Schaeffer was the founding Chairman and CEO of WellPoint, the nation’s largest health benefits company by membership. He is currently the […]

FOR IMMEDIATE RELEASE: Boston, MA – scPharmaceuticals LLC today announced that it has entered into a strategic partnership and product development agreement with Sensile Medical Holding AG of Zug, Switzerland to develop an innovative new therapeutic option for patients with heart failure.  The terms of the agreement were not disclosed. The drug-device combination uses the […]

Series A co-led by 5AM Ventures and Lundbeckfond Ventures FOR IMMEDIATE RELEASE Lexington, MA – scPharmaceuticals, Inc., a privately held pharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that it has closed a $16.0 million Series A venture financing round co-led by 5AM Ventures and Lundbeckfond Ventures. Proceeds from the financing will […]